|Publication number||US5180366 A|
|Application number||US 07/597,483|
|Publication date||Jan 19, 1993|
|Filing date||Oct 10, 1990|
|Priority date||Oct 10, 1990|
|Publication number||07597483, 597483, US 5180366 A, US 5180366A, US-A-5180366, US5180366 A, US5180366A|
|Inventors||W. T. Woods|
|Original Assignee||Woods W T|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (4), Referenced by (309), Classifications (6), Legal Events (4)|
|External Links: USPTO, USPTO Assignment, Espacenet|
The present invention relates to the treatment of cardiovascular disease. More specifically, the present invention relates to an apparatus and method for angioplasty that prevents re-stenosis.
Cardiovascular disease is the leading cause of death in the United States. Arteriosclerosis refers generally to a group of diseases in which the lumen of an artery becomes narrowed or blocked (occluded). The narrowing of the artery restricts blood flow to the organ that is nourished by the artery. The reduced blood flow results in the deterioration of the organ to the point wherein the organ can be permanently damaged unless the blockage of blood flow is removed.
When an artery that serves the heart is narrowed or blocked, this pathological process results in a heart attack. A variety of therapies have been developed to prevent heart attacks and to restore adequate blood flow to the heart. These therapies include dilating the artery utilizing a pharmaceutical, surgical intervention by replacing the blocked segment with a new segment (or coronary artery by-pass graft), or the use of a catheter-mounted mechanical device, such as a balloon.
Although in most cases, surgery is required to reestablish an occluded lumen to proper diameter, by-pass surgery and the like presents a number of disadvantages to the patient. By-pass surgery is quite expensive, creates a period of discomfort for the patient, and involves the surgical risks associated with any major surgery. Therefore, the focus recently has been on relatively noninvasive and less risky alternatives to conventional surgery.
One such method is known as angioplasty, or when used with coronary arteries, percutaneous transluminal coronary angioplasty. Generally, angioplasty is performed using a multilumen inflatable balloon catheter. At least one lumen of the catheter is open ended and allows the passage of a guide wire, or in some instances, the direct intra-arterial infusion of a pharmaceutical agent therethrough. In angioplasty, the guide wire is directed to the area of arterial narrowing using x-ray monitoring, for example, a roentgengraph or fluoroscope. Thereafter, the catheter is positioned with the aid of the guide wire in the region of arterial narrowing.
Concentric with the lumen that includes the guide wire is a second lumen that is connected to an elongated inflatable segment or balloon portion. This balloon portion is located near the distal end of the catheter and is constructed from a material having a high tensile strength and low elasticity. The second lumen and balloon are generally filled with diluted contrast medium. The contrast medium is a radiopaque liquid that makes the visualization of the catheter possible by fluoroscopy.
The typical angioplasty procedure involves the introduction of the catheter into the arterial system of the patient, for example, through the femoral artery of the leg. The catheter is then guided to the affected artery, for example, the left anterior descending coronary artery, manually with the aid of fluoroscopy.
Once the catheter is appropriately positioned in the affected artery, the guide wire is advanced to and past the point of obstruction. The balloon portion of the catheter, which surrounds the guide wire, is thereby advanced along the guide wire until it is in juxtaposition to the occluded segment. The balloon is then inflated. As the balloon expands, it pushes the occluding tissue toward the walls of the vessel. This correspondingly increases the diameter of the occluded artery.
Typically, the balloon is inflated and deflated a number of times. By repeatedly inflating and deflating the balloon, it is hoped that the corresponding repeated deformation of the occluding tissue will permanently deform the tissue thus providing the affected artery with a lumen having a sufficiently large inner diameter.
After the balloon has been inflated and deflated an arbitrary number of times, the balloon is then collapsed and retracted. The site of obstruction is then examined angiographically. This is often performed by injecting a radiopaque dye through the lumen housing the guide wire. If the artery is still occluded, the procedure is repeated.
Examples of such catheters include Medtronic Thruflex and Advanced Cardiovascular Systems catheters.
The popularity of angioplasties has increased dramatically. In the United States in 1989, hundreds of thousands of angioplasties were performed. This number is rapidly increasing. Fortunately, for many patients, angioplasty permanently reopens the previously occluded arteries. However, in 30% of the occluded arteries which are opened by an angioplasty technique, the arteries re-occlude within six months of the procedure. This results in symptoms of cardiac ischemia, such as chest pain, exercise intolerance, and shortness of breath. The patient's risk of disabling or fatal heart attack is markedly increased.
It is believed that re-stenosis in a previously treated segment of an artery is due to the stretch-induced damage of arterial tissue. The response to the damage caused by the inflation of the balloon catheter is an exaggerated healing response that includes proliferation of the undamaged tissue. The proliferating tissues are the endothelial cells that form the lining of the lumen and fibroblasts and smooth muscle cells that reside in the artery wall.
In attempting to prevent re-stenosis from occurring, vascular stents have been installed within the artery for the purpose of holding the lumen open. However, this has been found to be an unsatisfactory solution since proliferating tissue will grow around and through the stent lattice re-occluding the lumen. Accordingly, there is a need for preventing or reducing restenosis in arteries that have undergone angioplasty.
The present invention provides an angioplasty method and apparatus for performing same that reduces or eliminates restenosis in arteries that have undergone the angioplasty. The invention prevents the proliferative response. Pursuant to the present invention, growth and division of endothelial cells is promoted selectively, while inhibiting proliferation of other cells, such as fibroblasts and smooth muscle cells. Further, pursuant to the present invention, the endothelial cell lining of the lumen becomes complete (confluent) and proliferation of all other cell types is inhibited.
To this end, the present invention provides a method and apparatus for depositing a time release anti-proliferation agent in the artery wall. The anti-proliferation agents inhibit the proliferation of cells that cause re-stenosis.
In an embodiment, a multilumen catheter is provided having a distal end including an inflatable balloon and means for implanting an anti-proliferation agent in a lining of a vessel wall located in juxtaposition to the balloon.
In an embodiment, the anti-proliferation agent is at least one agent chosen from the group consisting of: antibiotics; anti-metabolites; cytotoxic agents; steroids; hormones; antiparasitics; anti-platelet; anticoagulants; calcium channel blockers; anti-hyperlipemics; alpha receptor blockers; beta receptor blockers; anti-connective tissue agents; anti-smooth muscle agents; and endothelial growth stimulators.
In an embodiment, a multilumen catheter for performing angioplasty and limiting or preventing re-stenosis is provided comprising a shaft defining a first lumen. An inflatable balloon is located at an end of the shaft. A drug delivery collar including a plurality of perforations for receiving at least one anti-proliferative agent is located in juxtaposition to said balloon. And the catheter includes means for embedding the anti-proliferation agents in the collar in tissue in a vessel.
In an embodiment, the collar includes a plurality of perforations or chambers for receiving the anti-proliferative agent and is so constructed and arranged that upon the application of a sufficient pressure through the catheter the anti-proliferative agents are expelled from the perforations.
The present invention also provides a method for increasing the diameter of an occluded vessel comprising the steps of: inserting a catheter having an inflatable balloon and means for implanting anti-proliferative agents into a predetermined vessel; positioning the means for implanting in juxtaposition to the occluded portion of the vessel; implanting an anti-proliferation agent into the lining of the occluded portion of the vessel; locating the balloon in juxtaposition to the occluded portion of the vessel; and inflating and deflating the balloon at least once to increase the diameter of the occluded vessel.
In an embodiment of the method, suction is applied by the catheter within th vessel prior to the implantation step to pull tissue of the vessel near the means for implanting.
In an embodiment of the method, the anti-proliferation agent is implanted by pulsing a pressure through the catheter.
In an embodiment of the method, after the anti-proliferation agent is implanted, the balloon catheter is inflated to further embed the agent in the tissue.
Additional features and advantages of the present invention are described in, and will be apparent from, the detailed description of the presently preferred embodiments and from the drawings.
FIG. 1 illustrates a perspective view of an embodiment of the catheter of the present invention.
FIG. 2 illustrates a cross-sectional enlarged view of a portion of the catheter in an occluded artery.
FIG. 3 illustrates a cross-sectional view of the catheter of FIG. 2 taken along lines III--III of FIG. 2.
FIG. 4 illustrates a detailed cross-sectional view of a perforation in the collar of the catheter of FIG. 2.
The present invention provides an apparatus and method for removing arterial occlusions and eliminating or limiting re-stenosis. Although angioplasty is a procedure of choice for reopening occluded blood vessels, due to its relative safety, a major draw back is that approximately 30% of the treated vessels reocclude within six months. The re-stenosis usually results due to an over proliferation of cells in the treated areas. Pursuant to the device and method of the present invention, occluded arteries are opened and time releasable drugs are implanted in the artery walls. The implanted drugs inhibit cell proliferation that causes re-stenosis.
Referring now to FIG. 1, a multi-lumen catheter 10 is illustrated. The catheter 10 of the present invention includes a first shaft or lumen 12 that extends from a first end 13 of the catheter to a distal end 16 of the catheter. The lumen 12 is preferably surrounded by a steel spring coil having a polyethylene outer jacket.
Located within the first lumen 12 is a second lumen or guide wire 18. As is known in the art, the guide wire 18 functions to guide the catheter 10 to the desired location within a vessel 19.
Located preferably at the distal end 16 of the catheter 10 and secured to the first shaft 12 is an inflatable member such as a balloon lumen 20. The balloon lumen 20 preferably is constructed from a material having a high tensile strength and low elasticity. For example, the balloon lumen 20 can be constructed from an inflatable polyethylene material.
Located at the first end 13 of the catheter 10 are two ports 22 and 24. The first port 24 functions to receive the guide wire 18 and the second port 22 provides a means for inflating the balloon portion 20 of the catheter when the catheter 10 is in proper position. In these regards, the catheter 10 generally is similar to catheters such as Medtronic Model 18K-20-25E catheter.
In contrast to a standard catheter, however, the present invention provides a catheter that includes means for delivering an anti-proliferation agent to select tissue in the vessel. The anti-proliferation agent prevents re-stenosis by preventing cell proliferation after the angioplasty. In the preferred embodiment illustrated, the means for delivering an anti-proliferation agent is a drug delivery collar 26. As illustrated in FIG. 2, the drug delivery collar 26 is located around the distal end 16 of the catheter 10 and a portion of the balloon lumen 20.
The drug delivery collar 26 includes a plurality of perforations (holes) or chambers 28. Each of the perforations 28 is filled with an anti-proliferation agent, preferably drug delivery pellets. For example, theoretically, for a 0.4 millimeter in diameter (a in FIG. 4) ×0.4 millimeter deep (b in FIG. 4) hole, approximately 50×103 (50,000) drug pellets having a 10 micron diameter can be housed therein.
Referring now to FIG. 4, a cross-sectional view of a perforation 28 and the drug delivery collar 26 is illustrated. The drug delivery collar 26 preferably is constructed from a stainless steel tube having a plurality of perforations 28. The inner surface 32 of the drug delivery collar 26 includes a flexible floor or lining 34. The perforations 28 terminate in an opening 36 in fluid communication with the outside environment.
The flexible lining 34 of the drug delivery collar 26 is so constructed and arranged so that it will allow the pellets 38 contained within the chambers 28 to be expelled therefrom upon a pulse of a sufficient pressure through the interior defined by the collar. It has been found that a layer of polyethylene approximately 30 microns thick functions satisfactorily in this regard. The polyethylene can be applied on the interior 32 of the collar 26 as a liquid and then dries as a film.
To fill the collar 26, the collar can be submerged in the applicable drug delivery pellets containing the antiproliferation agent. The collar 26 is then agitated causing the pellets 38 to be received within the perforations 28 of the collar. Excess pellets 28 that adhere to the collar 26 outside the perforations can be removed by brushing the collar.
As stated above, the drugs that are located within the perforations are drugs that inhibit the cell proliferation that causes re-stenosis. Examples of such anti-proliferation agents include: antibiotics (e.g., adriamycin, Adria); anti-metabolites (e.g., methotrexate, Lederle); cytotoxic agents (e.g., cytoxan, Bristol-Myers); steroids (e.g., celestrone, Schering); hormones (e.g., estrogen, Upjohn); antiparasitics (e.g., chloroquine, Winthrop); anti-platelet (e.g., salicylates, SmithKline); anticoagulants (e.g., heparin, Wyeth-Ayerst); calcium channel blockers (e.g., cardizem, Marion Merrell Dow); anti-hyperlipemics (e.g., mevacor, Merck), alpha receptor blockers (e.g., hytrin, Abbott); beta receptor blockers (e.g., sectral, Wyeth-Ayerst); anti-connective tissue agents (e.g., neuraminidase, Sigma); antismooth muscle agents (e.g., cicletanide, Sigma); and endothelial growth stimulators (e.g., endothelial growth factor, Genentech). A preferred agent for use in the present invention is chloroquine (e.g., Aralen by Winthrop). Of course, the agents can be used in combination.
Preferably, the pellets 38 are constructed of a polymeric material such as polyethylene or metallic beads coated with a polymeric material. The polymeric material forms a matrix that includes the agent. Examples of such polymeric material are available from Promeon, Inc. (Minneapolis). The polymeric material is designed to release the drug or agent at a steady rate, for example six months. Each pellet can be coated with a laminin (Cooper Biomedical), a naturally occurring protein that adheres to living tissue surfaces.
By way of example, and not limitation, an example of the catheter of the present invention is as follows.
The balloon lumen 20 shaft's outside diameter is 0.038 inches concentric to a 0.035 inch outside diameter lumen and is coated with silicon (0.018 inch diameter). The overall catheter 10 length is approximately 56 inches. The outside diameter is 0.038 inch (3.5 French) except the final 0.75 inch tip which has an 0.031 inch outside diameter. The inside diameter of the tip is 0.020 inches. The balloon's 20 length is 30 millimeters, the diameter is 2.5 millimeters when inflated to a pressure of 5 atmospheres.
The collar 26 is located so that it covers approximately 10 millimeters of the length of the balloon 20. In this regard, the collar is approximately 10 millimeters in length and made of 0.4 millimeter thick stainless steel or other rigid material perforated by approximately 100, 0.4 millimeter diameter, chambers 28 having a depth of 0.4 millimeters. The collar has an outside diameter of 3.0 millimeters and an inside diameter of 2.2 millimeters. The collar's 26 inner surface 32 is lined with a layer 34 of polyethylene 30 millimeters thick which forms the floor of each perforation 28 in the collar 26.
The catheter 10 is advanced through the vessel 19 so that the collar 26 is positioned so that it is surrounded by the atheroma 39 as illustrated in FIG. 2. The balloon 20 is then inflated to two atmospheres pressure to occlude the distal artery lumen and press the inner lining 32 of the collar 26 firmly against the floor 34 of each pellet containing chamber or perforation 28.
A negative 1.0 atmosphere pressure is applied to the lumen of the guide catheter 10. This creates a negative pressure within the narrow region and pulls the arterial tissue 39 into contact with the drug delivery collar 26.
A square wave pressure pulse of 20 atmospheres is then delivered for 100 milliseconds to the balloon 20. The pressure is delivered through a port 22 that communicates with a pulse generator (not illustrated). Examples of pulse generators that can be utilized are piston driven devices available from Medical Engineering Consultants or compressed gas devices available from, for example, Daisy Corporation.
The pulse within the balloon 20 drives the flexible lining 32 of the pellet containing perforations 28 outward propelling the pellets 38 toward the narrowed arterial tissue 39. The pellets 38 adhere to and embed within the artery tissue 39 and drugs begin to elute from them. The balloon 20 is deflated.
The catheter 10 is then positioned so that the balloon 20 is located in the narrowed arterial region. The balloon 20 is inflated again to a pressure of 5 atmospheres or more to dilate the narrow region and to promote adhesion between the pellets and arterial tissue 39. After two minutes or so, and multiple inflations of the balloon, or other appropriate time determined by the physician, the balloon 20 is deflated and the pellet implanting balloon catheter is retracted into the guide catheter which is then removed from the patient.
It should be understood that various changes and modifications to the presently preferred embodiments described herein will be apparent to those skilled in the art. Such changes and modifications can be made without departing from the spirit and scope of the present invention and without diminishing its attendant advantages. It is therefore intended that such changes and modifications be covered by the appended claims.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US4423725 *||Mar 31, 1982||Jan 3, 1984||Baran Ostap E||Multiple surgical cuff|
|US4693243 *||Mar 26, 1986||Sep 15, 1987||Buras Sharon Y||Conduit system for directly administering topical anaesthesia to blocked laryngeal-tracheal areas|
|US4994033 *||May 25, 1989||Feb 19, 1991||Schneider (Usa) Inc.||Intravascular drug delivery dilatation catheter|
|WO1989012478A1 *||Jun 21, 1989||Dec 28, 1989||Hansjoerg Just||Dilatation catheter|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US5257974 *||Aug 19, 1992||Nov 2, 1993||Scimed Life Systems, Inc.||Performance enhancement adaptor for intravascular balloon catheter|
|US5304195 *||Jan 21, 1993||Apr 19, 1994||Target Therapeutics, Inc.||Detachable pusher-vasoocclusive coil assembly with interlocking coupling|
|US5338300 *||Jul 28, 1993||Aug 16, 1994||Scimed Life Systems, Inc.||Performance enhancement adaptor for intravascular balloon catheter|
|US5397307 *||Dec 7, 1993||Mar 14, 1995||Schneider (Usa) Inc.||Drug delivery PTCA catheter and method for drug delivery|
|US5415636 *||Apr 13, 1994||May 16, 1995||Schneider (Usa) Inc||Dilation-drug delivery catheter|
|US5514092 *||Aug 8, 1994||May 7, 1996||Schneider (Usa) Inc.||Drug delivery and dilatation-drug delivery catheters in a rapid exchange configuration|
|US5536250 *||Sep 13, 1994||Jul 16, 1996||Localmed, Inc.||Perfusion shunt device and method|
|US5545569 *||May 25, 1995||Aug 13, 1996||Neorx Corporation||Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells|
|US5562620 *||Mar 10, 1995||Oct 8, 1996||Localmed, Inc.||Perfusion shunt device having non-distensible pouch for receiving angioplasty balloon|
|US5571086 *||Apr 1, 1994||Nov 5, 1996||Localmed, Inc.||Method and apparatus for sequentially performing multiple intraluminal procedures|
|US5588962 *||Mar 29, 1994||Dec 31, 1996||Boston Scientific Corporation||Drug treatment of diseased sites deep within the body|
|US5595722 *||Jun 7, 1995||Jan 21, 1997||Neorx Corporation||Method for identifying an agent which increases TGF-beta levels|
|US5599298 *||Dec 30, 1993||Feb 4, 1997||Boston Scientific Corporation||Bodily sample collection balloon catheter method|
|US5599306 *||Sep 29, 1995||Feb 4, 1997||Localmed, Inc.||Method and apparatus for providing external perfusion lumens on balloon catheters|
|US5599307 *||Sep 29, 1995||Feb 4, 1997||Loyola University Of Chicago||Catheter and method for the prevention and/or treatment of stenotic processes of vessels and cavities|
|US5603698 *||Aug 23, 1995||Feb 18, 1997||Boston Scientific Corporation||Prosthesis delivery system|
|US5605696 *||Mar 30, 1995||Feb 25, 1997||Advanced Cardiovascular Systems, Inc.||Drug loaded polymeric material and method of manufacture|
|US5609574 *||May 11, 1994||Mar 11, 1997||Localmed, Inc.||Intravascular catheter with infusion array|
|US5632840 *||Jun 6, 1995||May 27, 1997||Advanced Cardiovascular System, Inc.||Method of making metal reinforced polymer stent|
|US5634901 *||Oct 20, 1994||Jun 3, 1997||Localmed, Inc.||Method of using a catheter sleeve|
|US5649977 *||Sep 22, 1994||Jul 22, 1997||Advanced Cardiovascular Systems, Inc.||Metal reinforced polymer stent|
|US5674192 *||Jul 23, 1993||Oct 7, 1997||Boston Scientific Corporation||Drug delivery|
|US5713860 *||Jun 5, 1995||Feb 3, 1998||Localmed, Inc.||Intravascular catheter with infusion array|
|US5733925 *||Oct 28, 1996||Mar 31, 1998||Neorx Corporation||Therapeutic inhibitor of vascular smooth muscle cells|
|US5746717 *||Mar 23, 1994||May 5, 1998||Aigner; Karl R.||Balloon catheter and device for perfusion with the balloon catheter|
|US5770609 *||Jun 7, 1995||Jun 23, 1998||Neorx Corporation||Prevention and treatment of cardiovascular pathologies|
|US5772629 *||Oct 23, 1995||Jun 30, 1998||Localmed, Inc.||Localized intravascular delivery of TFPI for inhibition of restenosis in recanalized blood vessels|
|US5772632 *||Aug 4, 1997||Jun 30, 1998||Schneider (Usa) Inc.||Dilation-drug delivery catheter|
|US5811447 *||May 25, 1995||Sep 22, 1998||Neorx Corporation||Therapeutic inhibitor of vascular smooth muscle cells|
|US5833705 *||Sep 20, 1996||Nov 10, 1998||Target Therapeutics, Inc.||Stretch resistant vaso-occlusive coils|
|US5837313 *||Jun 13, 1996||Nov 17, 1998||Schneider (Usa) Inc||Drug release stent coating process|
|US5843089 *||Sep 20, 1996||Dec 1, 1998||Boston Scientific Corporation||Stent lining|
|US5847007 *||May 12, 1994||Dec 8, 1998||Neorx Corporation||Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells|
|US5866561 *||Aug 21, 1997||Feb 2, 1999||Scimed Life Systems, Inc.||Local delivery of estrogen for angiogenesis|
|US5868719 *||Jan 15, 1997||Feb 9, 1999||Boston Scientific Corporation||Drug delivery balloon catheter device|
|US5876374 *||May 30, 1997||Mar 2, 1999||Localmed, Inc.||Catheter sleeve for use with a balloon catheter|
|US5902333 *||Aug 21, 1995||May 11, 1999||Boston Scientific Corporation||Prosthesis delivery system with dilating tip|
|US5919145 *||Jan 24, 1997||Jul 6, 1999||Boston Scientific Corporation||Bodily sample collection balloon catheter|
|US5941868 *||Nov 22, 1996||Aug 24, 1999||Localmed, Inc.||Localized intravascular delivery of growth factors for promotion of angiogenesis|
|US5954706 *||Jun 7, 1995||Sep 21, 1999||Boston Scientific Corporation||Drug delivery|
|US5980972 *||Sep 22, 1997||Nov 9, 1999||Schneider (Usa) Inc||Method of applying drug-release coatings|
|US5981568 *||Mar 31, 1997||Nov 9, 1999||Neorx Corporation||Therapeutic inhibitor of vascular smooth muscle cells|
|US5984964 *||Oct 31, 1996||Nov 16, 1999||Boston Scientific Corporation||Prothesis delivery system|
|US6004338 *||Aug 11, 1998||Dec 21, 1999||Target Therapeutics Inc.||Stretch resistant vaso-occlusive coils|
|US6071305 *||Nov 24, 1997||Jun 6, 2000||Alza Corporation||Directional drug delivery stent and method of use|
|US6074659 *||Jul 10, 1998||Jun 13, 2000||Noerx Corporation||Therapeutic inhibitor of vascular smooth muscle cells|
|US6092526 *||Jun 19, 1997||Jul 25, 2000||Scimed Life Systems, Inc.||Percutaneous chamber-to-artery bypass|
|US6099562 *||Dec 22, 1997||Aug 8, 2000||Schneider (Usa) Inc.||Drug coating with topcoat|
|US6120536 *||Jun 13, 1996||Sep 19, 2000||Schneider (Usa) Inc.||Medical devices with long term non-thrombogenic coatings|
|US6149641 *||Dec 23, 1998||Nov 21, 2000||Scimed Life Systems, Inc.||Local delivery of estrogen for angiogenesis|
|US6166090 *||Nov 6, 1997||Dec 26, 2000||Neorx Corporation||Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells|
|US6171609||Oct 23, 1995||Jan 9, 2001||Neorx Corporation||Therapeutic inhibitor of vascular smooth muscle cells|
|US6193728||Nov 4, 1999||Feb 27, 2001||Target Therapeutics, Inc.||Stretch resistant vaso-occlusive coils (II)|
|US6197324||Jul 15, 1998||Mar 6, 2001||C. R. Bard, Inc.||System and methods for local delivery of an agent|
|US6197789||Jun 7, 1996||Mar 6, 2001||Neorx Corporation||Prevention and treatment of cardiovascular pathologies with tamoxifen analogues|
|US6251136||Dec 8, 1999||Jun 26, 2001||Advanced Cardiovascular Systems, Inc.||Method of layering a three-coated stent using pharmacological and polymeric agents|
|US6251418||Dec 18, 1997||Jun 26, 2001||C.R. Bard, Inc.||Systems and methods for local delivery of an agent|
|US6251920||May 21, 1998||Jun 26, 2001||Neorx Corporation||Prevention and treatment of cardiovascular pathologies|
|US6262079||May 6, 1999||Jul 17, 2001||Neorx Corporation||Prevention and treatment of cardiovascular pathologies|
|US6268390||Dec 22, 1999||Jul 31, 2001||Neorx Corporation||Therapeutic inhibitor of vascular smooth muscle cells|
|US6277082||Jul 22, 1999||Aug 21, 2001||C. R. Bard, Inc.||Ischemia detection system|
|US6284305||May 18, 2000||Sep 4, 2001||Schneider (Usa) Inc.||Drug coating with topcoat|
|US6306421||Mar 31, 1997||Oct 23, 2001||Neorx Corporation||Therapeutic inhibitor of vascular smooth muscle cells|
|US6358556||Jan 23, 1998||Mar 19, 2002||Boston Scientific Corporation||Drug release stent coating|
|US6358989||Jul 26, 1999||Mar 19, 2002||Neorx Corporation||Therapeutic inhibitor of vascular smooth muscle cells|
|US6364893||Aug 5, 1998||Apr 2, 2002||Scimed Life Systems, Inc.||Stent lining|
|US6395494||Jun 7, 1995||May 28, 2002||Neorx Corporation||Method to determine TGF-β|
|US6409716||Oct 7, 1997||Jun 25, 2002||Scimed Life Systems, Inc.||Drug delivery|
|US6432126||Sep 30, 1998||Aug 13, 2002||C.R. Bard, Inc.||Flexible vascular inducing implants|
|US6447522||Jun 18, 2001||Sep 10, 2002||C. R. Bard, Inc.||Implant delivery system|
|US6458092||Sep 30, 1998||Oct 1, 2002||C. R. Bard, Inc.||Vascular inducing implants|
|US6464662||Jul 26, 2000||Oct 15, 2002||Image-Guided Neurologics, Inc.||Drug delivery and catheter systems, apparatus and processes|
|US6475235||Nov 16, 1999||Nov 5, 2002||Iowa-India Investments Company, Limited||Encapsulated stent preform|
|US6491938||Jun 29, 2001||Dec 10, 2002||Neorx Corporation||Therapeutic inhibitor of vascular smooth muscle cells|
|US6494861||Jan 15, 1997||Dec 17, 2002||Boston Scientific Corporation||Drug delivery system|
|US6515009||Feb 15, 1995||Feb 4, 2003||Neorx Corporation||Therapeutic inhibitor of vascular smooth muscle cells|
|US6524274||Jun 7, 1995||Feb 25, 2003||Scimed Life Systems, Inc.||Triggered release hydrogel drug delivery system|
|US6569441||Nov 27, 2001||May 27, 2003||Neorx Corporation||Therapeutic inhibitor of vascular smooth muscle cells|
|US6599928||Jul 20, 2001||Jul 29, 2003||Neorx Corporation||Therapeutic inhibitor of vascular smooth muscle cells|
|US6620170||Apr 26, 1999||Sep 16, 2003||C. R. Bard, Inc.||Devices and methods for treating ischemia by creating a fibrin plug|
|US6620194||Aug 30, 2001||Sep 16, 2003||Boston Scientific Scimed, Inc.||Drug coating with topcoat|
|US6629987||Jul 30, 1999||Oct 7, 2003||C. R. Bard, Inc.||Catheter positioning systems|
|US6635082||Dec 29, 2000||Oct 21, 2003||Advanced Cardiovascular Systems Inc.||Radiopaque stent|
|US6641607||Dec 29, 2000||Nov 4, 2003||Advanced Cardiovascular Systems, Inc.||Double tube stent|
|US6652574||Sep 28, 2000||Nov 25, 2003||Vascular Concepts Holdings Limited||Product and process for manufacturing a wire stent coated with a biocompatible fluoropolymer|
|US6663881||Dec 18, 2001||Dec 16, 2003||Neorx Corporation||Therapeutic inhibitor of vascular smooth muscle cells|
|US6689121||Sep 24, 1998||Feb 10, 2004||C. R. Bard, Inc.||Systems and methods for treating ischemia|
|US6692520||Dec 15, 1998||Feb 17, 2004||C. R. Bard, Inc.||Systems and methods for imbedded intramuscular implants|
|US6702849||Dec 13, 1999||Mar 9, 2004||Advanced Cardiovascular Systems, Inc.||Method of processing open-celled microcellular polymeric foams with controlled porosity for use as vascular grafts and stent covers|
|US6709425||Jan 31, 2001||Mar 23, 2004||C. R. Bard, Inc.||Vascular inducing implants|
|US6719805||Jun 9, 1999||Apr 13, 2004||C. R. Bard, Inc.||Devices and methods for treating tissue|
|US6720350||Dec 27, 2002||Apr 13, 2004||Scimed Life Systems, Inc.||Therapeutic inhibitor of vascular smooth muscle cells|
|US6746478||Nov 4, 2002||Jun 8, 2004||Vascular Concepts Holdings Limited||Stent formed from encapsulated stent preforms|
|US6773719||Aug 7, 2001||Aug 10, 2004||Esperion Luv Development, Inc.||Liposomal compositions, and methods of using liposomal compositions to treat dislipidemias|
|US6776796||May 7, 2001||Aug 17, 2004||Cordis Corportation||Antiinflammatory drug and delivery device|
|US6786929||Nov 21, 2001||Sep 7, 2004||C. R. Bard, Inc.||Flexible vascular inducing implants and methods|
|US6802858||Jan 31, 2001||Oct 12, 2004||C.R. Bard, Inc.||Vascular inducing implants|
|US6855160||Aug 3, 2000||Feb 15, 2005||C. R. Bard, Inc.||Implant and agent delivery device|
|US6890339||Jan 31, 2002||May 10, 2005||Scimed Life Systems, Inc.||Stent lining|
|US6890583||Nov 21, 2001||May 10, 2005||Surmodics, Inc.||Bioactive agent release coating|
|US6945949||Jul 1, 2002||Sep 20, 2005||Percardia, Inc.||Left ventricular conduits to coronary arteries and methods for coronary bypass|
|US6949080||Aug 15, 2002||Sep 27, 2005||Percardia, Inc.||Left ventricular conduits to coronary arteries and methods for coronary bypass|
|US6949117||Jan 29, 2004||Sep 27, 2005||C. R. Bard, Inc.||Vascular inducing implants|
|US6986784||May 12, 2000||Jan 17, 2006||C. R. Bard, Inc.||Implant anchor systems|
|US7000305||Nov 24, 2003||Feb 21, 2006||Vascular Concepts Holding Limited||Method for manufacturing a wire stent coated with a biocompatible fluoropolymer|
|US7008667||Oct 10, 2002||Mar 7, 2006||Surmodics, Inc.||Bioactive agent release coating|
|US7056550||Aug 7, 2003||Jun 6, 2006||Ethicon, Inc. - Usa||Medical devices, drug coatings and methods for maintaining the drug coatings thereon|
|US7066904||Oct 25, 2002||Jun 27, 2006||Boston Scientific Scimed, Inc.||Triggered release hydrogel drug delivery system|
|US7094550||Mar 26, 2002||Aug 22, 2006||Neorx Corporation||Method to determine TGF-beta|
|US7097850||Jun 18, 2002||Aug 29, 2006||Surmodics, Inc.||Bioactive agent release coating and controlled humidity method|
|US7101570||Nov 5, 2001||Sep 5, 2006||The University Of British Columbia||Liposome compositions and methods for the treatment of atherosclerosis|
|US7108701||Oct 21, 2002||Sep 19, 2006||Ethicon, Inc.||Drug releasing anastomosis devices and methods for treating anastomotic sites|
|US7147655||Mar 29, 2002||Dec 12, 2006||Xtent, Inc.||Balloon catheter for multiple adjustable stent deployment|
|US7195640||Apr 15, 2002||Mar 27, 2007||Cordis Corporation||Coated medical devices for the treatment of vulnerable plaque|
|US7204847||Jul 28, 2000||Apr 17, 2007||C. R. Bard, Inc.||Implant anchor systems|
|US7211108||Jan 23, 2004||May 1, 2007||Icon Medical Corp.||Vascular grafts with amphiphilic block copolymer coatings|
|US7232421||May 12, 2000||Jun 19, 2007||C. R. Bard, Inc.||Agent delivery systems|
|US7238469||Jun 21, 2002||Jul 3, 2007||Beth Israel Deaconess Medical Center, Inc.||Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis|
|US7261735||Jun 22, 2001||Aug 28, 2007||Cordis Corporation||Local drug delivery devices and methods for maintaining the drug coatings thereon|
|US7294115||Mar 24, 2000||Nov 13, 2007||Percardia, Inc.||Methods of providing direct blood flow between a heart chamber and a coronary vessel|
|US7320702||Jun 8, 2005||Jan 22, 2008||Xtent, Inc.||Apparatus and methods for deployment of multiple custom-length prostheses (III)|
|US7364757||Feb 13, 2003||Apr 29, 2008||University Of Pittsburgh Of The Commonwealth System Of Higher Education||Methods of treating vascular disease|
|US7442402||Nov 17, 2005||Oct 28, 2008||Surmodics, Inc.||Bioactive agent release coating|
|US7445628||Apr 14, 2003||Nov 4, 2008||Cook Incorporated||Method of treating a patient with a coated implantable medical device|
|US7481790||Dec 27, 2000||Jan 27, 2009||Advanced Cardiovascular Systems, Inc.||Vessel enlargement by arteriogenic factor delivery|
|US7488444||Jan 24, 2006||Feb 10, 2009||Icon Medical Corp.||Metal alloys for medical devices|
|US7541048||Apr 6, 2005||Jun 2, 2009||Surmodics, Inc.||Coating compositions for bioactive agents|
|US7544673||Apr 6, 2005||Jun 9, 2009||Surmodics, Inc.||Coating compositions for bioactive agents|
|US7550005 *||Aug 14, 2002||Jun 23, 2009||Cook Incorporated||Coated implantable medical device|
|US7611532 *||Aug 14, 2002||Nov 3, 2009||Cook Incorporated||Coated implantable medical device|
|US7678390||Jan 15, 2002||Mar 16, 2010||Yale University||Carbon monoxide as a biomarker and therapeutic agent|
|US7687079||Feb 21, 2003||Mar 30, 2010||University of Pittsburgh of the Commonwealth System of Higher Education Yale University||Methods of treating ileus|
|US7691416||Mar 18, 2008||Apr 6, 2010||Beth Israel Deaconess Medical Center, Inc.||Methods of treating vascular disease|
|US7799070||Oct 31, 2007||Sep 21, 2010||Cook Incorporated||Coated implantable medical device|
|US7811622||Oct 31, 2007||Oct 12, 2010||Cook Incorporated||Coated implantable medical device|
|US7833548||Aug 19, 2005||Nov 16, 2010||Surmodics, Inc.||Bioactive agent release coating and controlled humidity method|
|US7846202||Dec 27, 2007||Dec 7, 2010||Cook Incorporated||Coated implantable medical device|
|US7867275||Sep 1, 2006||Jan 11, 2011||Cook Incorporated||Coated implantable medical device method|
|US7873404||May 29, 2009||Jan 18, 2011||Seth Caplan||Method for performing angioplasty and angiography with a single catheter|
|US7896914||Oct 31, 2007||Mar 1, 2011||Cook Incorporated||Coated implantable medical device|
|US7901453||Oct 31, 2007||Mar 8, 2011||Cook Incorporated||Coated implantable medical device|
|US7927305 *||Apr 20, 2007||Apr 19, 2011||Abbott Laboratories||Systems, methods, and devices for injecting media contrast|
|US7938851||Jun 8, 2005||May 10, 2011||Xtent, Inc.||Devices and methods for operating and controlling interventional apparatus|
|US7967855||Nov 18, 2005||Jun 28, 2011||Icon Interventional Systems, Inc.||Coated medical device|
|US7981448||Apr 15, 2003||Jul 19, 2011||University Of Pittsburgh||Methods of treating necrotizing enterocolitis|
|US7993303||Apr 20, 2007||Aug 9, 2011||Abbott Laboratories||Stiffening support catheter and methods for using the same|
|US8016881||Sep 7, 2004||Sep 13, 2011||Icon Interventional Systems, Inc.||Sutures and surgical staples for anastamoses, wound closures, and surgical closures|
|US8067022||Jul 20, 2001||Nov 29, 2011||Boston Scientific Scimed, Inc.||Therapeutic inhibitor of vascular smooth muscle cells|
|US8097585||Apr 15, 2003||Jan 17, 2012||Beth Israel Deaconess Medical Center, Inc.||Methods of treating inflammation by administration of heme oxygenase-1 and products of heme degradation|
|US8097642||Feb 27, 2007||Jan 17, 2012||Boston Scientific Scimed, Inc.||Therapeutic inhibitor of vascular smooth muscle cells|
|US8100963||Dec 28, 2006||Jan 24, 2012||Icon Medical Corp.||Biodegradable device|
|US8114152||Nov 10, 2008||Feb 14, 2012||Icon Interventional Systems, Inc.||Stent coating|
|US8128690||Jul 15, 2010||Mar 6, 2012||Advanced Bio Prosthetic Surfaces, Ltd.||Endoluminal device for in vivo delivery of bioactive agents|
|US8128963||Oct 3, 2003||Mar 6, 2012||The Trustees Of Columbia University In The City Of New York||Methods for treating ischemic disorders using carbon monoxide|
|US8142487||Jul 15, 2009||Mar 27, 2012||Xtent, Inc.||Balloon catheter for multiple adjustable stent deployment|
|US8147536||Jul 15, 2009||Apr 3, 2012||Xtent, Inc.||Balloon catheter for multiple adjustable stent deployment|
|US8157851||Jun 8, 2005||Apr 17, 2012||Xtent, Inc.||Apparatus and methods for deployment of multiple custom-length prostheses|
|US8158670||Jan 4, 2007||Apr 17, 2012||Boston Scientific Scimed, Inc.||Therapeutic inhibitor of vascular smooth muscle cells|
|US8172783||Dec 30, 1999||May 8, 2012||Advanced Cardiovascular Systems, Inc||Conduit system for isolation of fluids in biological tissues|
|US8182527||Jun 21, 2004||May 22, 2012||Cordis Corporation||Heparin barrier coating for controlled drug release|
|US8206370||Apr 20, 2007||Jun 26, 2012||Abbott Laboratories||Dual lumen guidewire support catheter|
|US8236048||Apr 27, 2004||Aug 7, 2012||Cordis Corporation||Drug/drug delivery systems for the prevention and treatment of vascular disease|
|US8246574||Apr 20, 2007||Aug 21, 2012||Abbott Laboratories||Support catheter|
|US8246876||Aug 18, 2008||Aug 21, 2012||Cook Medical Technologies Llc||Embolization particles and method for making same|
|US8252044||Nov 17, 2000||Aug 28, 2012||Advanced Bio Prosthestic Surfaces, Ltd.||Device for in vivo delivery of bioactive agents and method of manufacture thereof|
|US8257433||Oct 31, 2007||Sep 4, 2012||Cook Medical Technologies Llc||Coated implantable medical device|
|US8277436||Mar 28, 2008||Oct 2, 2012||Advanced Cardiovascular Systems, Inc.||Vessel enlargement by arteriogenic factor delivery|
|US8303609||Sep 28, 2001||Nov 6, 2012||Cordis Corporation||Coated medical devices|
|US8415318||Jun 20, 2011||Apr 9, 2013||Vascular Biogenics Ltd.||Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy|
|US8439890||Nov 28, 2011||May 14, 2013||By-Pass, Inc.||Material delivery system|
|US8469943||Oct 12, 2010||Jun 25, 2013||Cook Medical Technologies Llc||Coated implantable medical device|
|US8556962||May 25, 2005||Oct 15, 2013||Cook Medical Technologies Llc||Coated implantable medical device|
|US8597720||Jan 21, 2008||Dec 3, 2013||Hemoteq Ag||Medical product for treating stenosis of body passages and for preventing threatening restenosis|
|US8603158||Mar 26, 2004||Dec 10, 2013||Icon Interventional Systems, Inc||Irradiated stent coating|
|US8669360||Sep 23, 2011||Mar 11, 2014||Boston Scientific Scimed, Inc.||Methods of converting amorphous drug substance into crystalline form|
|US8697175||Mar 5, 2012||Apr 15, 2014||Advanced Bio Prosthetic Surfaces, Ltd., A Wholly Owned Subsidiary Of Palmaz Scientific, Inc.||Endoluminal device for in vivo delivery of bioactive agents|
|US8740973||Jan 20, 2006||Jun 3, 2014||Icon Medical Corp.||Polymer biodegradable medical device|
|US8758428||Oct 31, 2007||Jun 24, 2014||Cook Medical Technologies Llc||Coated implantable medical device|
|US8808618||Apr 24, 2009||Aug 19, 2014||Icon Medical Corp.||Process for forming an improved metal alloy stent|
|US8889211||Sep 2, 2011||Nov 18, 2014||Boston Scientific Scimed, Inc.||Coating process for drug delivery balloons using heat-induced rewrap memory|
|US8945206||Jun 23, 2009||Feb 3, 2015||Cook Medical Technologies Llc||Methods for making implantable medical devices|
|US9019884||Nov 13, 2013||Apr 28, 2015||Blackberry Limited||Inactivity timer in a discontinuous reception configured system|
|US9034245||Feb 25, 2013||May 19, 2015||Icon Medical Corp.||Method for forming a tubular medical device|
|US9042974 *||Sep 12, 2005||May 26, 2015||New York University||Apparatus and method for monitoring and treatment of brain disorders|
|US9056152||Sep 23, 2011||Jun 16, 2015||Boston Scientific Scimed, Inc.||Medical device with crystalline drug coating|
|US9107605||Sep 9, 2004||Aug 18, 2015||Advanced Bio Prosthetic Surfaces, Ltd., A Wholly Owned Subsidiary Of Palmaz Scientific, Inc.||Device for in vivo delivery of bioactive agents and method of manufacture thereof|
|US9107899||Oct 5, 2012||Aug 18, 2015||Icon Medical Corporation||Metal alloys for medical devices|
|US9119739||Feb 27, 2013||Sep 1, 2015||J.W. Medical Systems Ltd.||Balloon catheter for multiple adjustable stent deployment|
|US9192697||Feb 9, 2011||Nov 24, 2015||Hemoteq Ag||Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis|
|US20010033867 *||Jun 25, 2001||Oct 25, 2001||Ahern John E.||Systems and methods for local delivery of an agent|
|US20020013275 *||Jul 20, 2001||Jan 31, 2002||Neorx Corporation||Therapeutic inhibitor of vascular smooth muscle cells|
|US20020032434 *||Nov 21, 2001||Mar 14, 2002||Chudzik Stephen J.||Bioactive agent release coating|
|US20020051730 *||Sep 28, 2001||May 2, 2002||Stanko Bodnar||Coated medical devices and sterilization thereof|
|US20020071902 *||Feb 4, 2002||Jun 13, 2002||Ni Ding||Drug release stent coating|
|US20020092535 *||Feb 5, 2002||Jul 18, 2002||Wilk Patent Development Corp.||Coronary artery by-pass method|
|US20020103456 *||Dec 27, 2000||Aug 1, 2002||Wouter Roorda||Vessel enlargement by arteriogenic factor delivery|
|US20020110588 *||Nov 5, 2001||Aug 15, 2002||The University Of British Columbia||Liposome compositions and methods for the treatment of atherosclerosis|
|US20020133183 *||Sep 28, 2001||Sep 19, 2002||Lentz David Christian||Coated medical devices|
|US20020155166 *||Jan 15, 2002||Oct 24, 2002||Yale University||Carbon monoxide as a biomarker and therapeutic agent|
|US20020182659 *||Mar 26, 2002||Dec 5, 2002||Neorx Corporation||Method to determine TGF-beta|
|US20030028243 *||Aug 14, 2002||Feb 6, 2003||Cook Incorporated||Coated implantable medical device|
|US20030028244 *||Aug 14, 2002||Feb 6, 2003||Cook Incorporated||Coated implantable medical device|
|US20030039638 *||Jun 21, 2002||Feb 27, 2003||Bach Fritz H.||Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis|
|US20030060877 *||Apr 15, 2002||Mar 27, 2003||Robert Falotico||Coated medical devices for the treatment of vascular disease|
|US20030065345 *||Oct 21, 2002||Apr 3, 2003||Kevin Weadock||Anastomosis devices and methods for treating anastomotic sites|
|US20030065346 *||Oct 21, 2002||Apr 3, 2003||Evens Carl J.||Drug releasing anastomosis devices and methods for treating anastomotic sites|
|US20030219496 *||Feb 13, 2003||Nov 27, 2003||Otterbein Leo E.||Methods of treating vascular disease|
|US20030219497 *||Feb 21, 2003||Nov 27, 2003||Otterbein Leo E.||Methods of treating ileus|
|US20030232087 *||Jun 18, 2002||Dec 18, 2003||Lawin Laurie R.||Bioactive agent release coating with aromatic poly(meth)acrylates|
|US20030232122 *||Jun 18, 2002||Dec 18, 2003||Chappa Ralph A.||Bioactive agent release coating and controlled humidity method|
|US20030236495 *||May 12, 2003||Dec 25, 2003||Kennedy Kenneth C.||Non-buckling balloon catheter|
|US20040005367 *||Apr 15, 2003||Jan 8, 2004||Otterbein Leo E.||Methods of treating necrotizing enterocolitis|
|US20040009216 *||Mar 31, 2003||Jan 15, 2004||Rodrigueza Wendi V.||Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease|
|US20040024449 *||Nov 19, 2001||Feb 5, 2004||Boyle Christhoper T.||Device for in vivo delivery of bioactive agents and method of manufacture thereof|
|US20040047909 *||Apr 14, 2003||Mar 11, 2004||Ragheb Anthony O.||Coated implantable medical device|
|US20040049265 *||Jun 24, 2003||Mar 11, 2004||Schneider (Usa) Inc.||Drug coating with topcoat|
|US20040052866 *||May 16, 2003||Mar 18, 2004||Otterbein Leo E.||Methods of treating hepatitis|
|US20040087996 *||Jun 27, 2003||May 6, 2004||C. R. Bard, Inc.||Catheter positioning systems|
|US20040102758 *||Aug 7, 2003||May 27, 2004||Davila Luis A.||Medical devices, drug coatings and methods for maintaining the drug coatings thereon|
|US20040111144 *||Dec 6, 2002||Jun 10, 2004||Lawin Laurie R.||Barriers for polymeric coatings|
|US20040131703 *||Jun 20, 2003||Jul 8, 2004||Bach Fritz H.||Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation|
|US20040137066 *||Oct 29, 2003||Jul 15, 2004||Swaminathan Jayaraman||Rationally designed therapeutic intravascular implant coating|
|US20040143321 *||Nov 10, 2003||Jul 22, 2004||Conor Medsystems, Inc.||Expandable medical device and method for treating chronic total occlusions with local delivery of an angiogenic factor|
|US20040186587 *||Jan 28, 2004||Sep 23, 2004||C.R. Bard, Inc.||Devices and methods for treating tissue|
|US20040219223 *||Jun 2, 2004||Nov 4, 2004||Scimed Life Systems, Inc.||Therapeutic inhibitor of vascular smooth muscle cells|
|US20040220239 *||Sep 25, 2003||Nov 4, 2004||Leland Shapiro||Inhibitors of serine protease activity methods and compositions for treatment of nitric oxide-induced clinical conditions|
|US20040224011 *||Jun 4, 2004||Nov 11, 2004||The University Of British Columbia||Liposomal compositions and methods of using the same to treat dyslipidemias|
|US20040228930 *||Sep 30, 2003||Nov 18, 2004||Billiar Timothy R.||Treatment for hemorrhagic shock|
|US20040229856 *||Jun 24, 2003||Nov 18, 2004||Baskaran Chandrasekar||Local delivery of 17-beta estradiol for preventing vascular intimal hyperplasia and for improving vascular endothelium function after vascular injury|
|US20040236366 *||Mar 2, 2004||Nov 25, 2004||Kennedy Kenneth C.||Non-buckling balloon catheter|
|US20040243097 *||May 24, 2004||Dec 2, 2004||Robert Falotico||Antiproliferative drug and delivery device|
|US20040258772 *||Jun 5, 2003||Dec 23, 2004||Otterbein Leo E.||Methods of treating angiogenesis, tumor growth, and metastasis|
|US20050004558 *||Jul 26, 2004||Jan 6, 2005||Gambale Richard A.||Flexible vascular inducing implants|
|US20050004663 *||Jun 21, 2004||Jan 6, 2005||Llanos Gerard H.||Heparin barrier coating for controlled drug release|
|US20050033261 *||Apr 27, 2004||Feb 10, 2005||Robert Falotico||Drug/drug delivery systems for the prevention and treatment of vascular disease|
|US20050038472 *||Sep 7, 2004||Feb 17, 2005||Icon Interventional Systems, Inc.||Sutures and surgical staples for anastamoses, wound closures, and surgical closures|
|US20050048133 *||Oct 3, 2003||Mar 3, 2005||The Trustees Of Columbia University In The City Of New York||Methods for treating ischemic disorders using carbon monoxide|
|US20050106210 *||Nov 16, 2004||May 19, 2005||Boston Scientific Scimed, Inc.||Medical device with drug|
|US20050165476 *||Jan 23, 2004||Jul 28, 2005||Furst Joseph G.||Vascular grafts with amphiphilic block copolymer coatings|
|US20050186241 *||Sep 9, 2004||Aug 25, 2005||Boyle Christopher T.||Device for in vivo delivery of bioactive agents and method of manufacture thereof|
|US20050187611 *||Apr 27, 2005||Aug 25, 2005||Boston Scientific Scimed, Inc.||Drug coating with topcoat|
|US20050208200 *||Apr 27, 2005||Sep 22, 2005||Boston Scientific Scimed, Inc.||Drug coating with topcoat|
|US20050220839 *||Apr 6, 2005||Oct 6, 2005||Dewitt David M||Coating compositions for bioactive agents|
|US20050220840 *||Apr 6, 2005||Oct 6, 2005||Dewitt David M||Coating compositions for bioactive agents|
|US20050220841 *||Apr 6, 2005||Oct 6, 2005||Dewitt David M||Coating compositions for bioactive agents|
|US20050222677 *||May 25, 2005||Oct 6, 2005||Bates Brian L||Coated implantable medical device|
|US20060029986 *||Sep 20, 2005||Feb 9, 2006||Grainger David J||Prevention and treatment of cardiovascular pathologies|
|US20060067968 *||Nov 17, 2005||Mar 30, 2006||Surmodics, Inc.||Bioactive agent release coating|
|US20060083772 *||Oct 6, 2005||Apr 20, 2006||Dewitt David M||Coating compositions for bioactive agents|
|US20060088654 *||Dec 6, 2005||Apr 27, 2006||Boston Scientific Scimed, Inc.||Drug release coated stent|
|US20060089705 *||Dec 6, 2005||Apr 27, 2006||Boston Scientific Scimed, Inc.||Drug release coated stent|
|US20060122690 *||Jan 23, 2006||Jun 8, 2006||Inflow Dynnamics||Stent device and method|
|US20060135560 *||Dec 5, 2003||Jun 22, 2006||Neorx Corporation||Prevention and treatment of cardiovascular pathologies with tamoxifen analogues|
|US20060190022 *||Jan 19, 2006||Aug 24, 2006||By-Pass, Inc.||Material delivery system|
|US20060195176 *||Apr 25, 2006||Aug 31, 2006||Cook Incorporated||Coated implantable medical device|
|US20060235503 *||Jun 15, 2006||Oct 19, 2006||Cordis Corporation||Local drug delivery devices and methods for maintaining the drug coatings thereon|
|US20060282147 *||Jun 8, 2005||Dec 14, 2006||Xtent, Inc., A Delaware Corporation||Apparatus and methods for deployment of multiple custom-length prostheses (1)|
|US20060282148 *||Jun 8, 2005||Dec 14, 2006||Xtent,Inc., A Delaware Corporation||Apparatus and methods for deployment of multiple custom-length prostheses (III)|
|US20060282149 *||Jun 8, 2005||Dec 14, 2006||Xtent, Inc., A Delaware Corporation||Apparatus and methods for deployment of multiple custom-length prostheses (II)|
|US20060282150 *||Jun 8, 2005||Dec 14, 2006||Xtent, Inc.||Devices and methods for operating and controlling interventional apparatus|
|US20070027521 *||Jun 1, 2006||Feb 1, 2007||Xtent, Inc., A Delaware Corporation||Apparatus and methods for deployment of multiple custom-length prostheses|
|US20070050010 *||Sep 1, 2006||Mar 1, 2007||Cook Incorporated||Coated implantable medical device|
|US20070134314 *||Jan 4, 2007||Jun 14, 2007||Boston Scientific Scimed, Inc.||Therapeutic inhibitor of vascular smooth muscle cells|
|US20070141109 *||Feb 7, 2007||Jun 21, 2007||Baskaran Chadrasekar||Local Deliver of 17-Beta Estradiol for Preventing Vascular Intimal Hyperplasia and for Improving Vascular Endothelium Function after Vascular Injury|
|US20070248637 *||Aug 19, 2005||Oct 25, 2007||Surmodics, Inc.||Bioactive agent release coating and controlled humidity method|
|US20070250149 *||Apr 20, 2007||Oct 25, 2007||Abbott Laboratories||Stiffening Support Catheters and Methods for Using the Same|
|US20070270779 *||Apr 20, 2007||Nov 22, 2007||Abbott Laboratories||Support Catheter|
|US20070293821 *||Apr 20, 2007||Dec 20, 2007||Abbott Laboratories||Systems, Methods, and Devices for Injecting Media Contrast|
|US20070299392 *||Jul 14, 2005||Dec 27, 2007||By-Pass, Inc.||Material Delivery System|
|US20080065014 *||Apr 20, 2007||Mar 13, 2008||Abbott Laboratories||Systems, Methods, and Devices to Facilitate Wire and Device Crossings of Obstructions in Body Lumens|
|US20080071345 *||Nov 29, 2007||Mar 20, 2008||Xtent, Inc.||Apparatus and methods for deployment of multiple custom-length prostheses (iii)|
|US20080132992 *||Jun 5, 2007||Jun 5, 2008||Cook Incorporated||Coated implantable medical device|
|US20080140001 *||Dec 12, 2006||Jun 12, 2008||By-Pass Inc.||Fluid Delivery Apparatus And Methods|
|US20080145394 *||Oct 31, 2007||Jun 19, 2008||Bates Brian L||Coated implantable medical device|
|US20080145396 *||Oct 31, 2007||Jun 19, 2008||Bates Brian L||Coated implantable medical device|
|US20080145398 *||Oct 31, 2007||Jun 19, 2008||Bates Brian L||Coated implantable medical device|
|US20080145399 *||Oct 31, 2007||Jun 19, 2008||Bates Brian L||Coated implantable medical device|
|US20080147166 *||Oct 31, 2007||Jun 19, 2008||Bates Brian L||Coated implantable medical device|
|US20080167609 *||Mar 18, 2008||Jul 10, 2008||Otterbein Leo E||Methods of treating vascular disease|
|US20080183268 *||Dec 27, 2007||Jul 31, 2008||Cook Incorporated||Coated implantable medical device|
|US20080306441 *||Apr 7, 2008||Dec 11, 2008||Wilson-Cook Medical Inc.||Non-buckling balloon catheter with spring loaded floating flexible tip|
|US20090276031 *||Nov 5, 2009||Xtent, Inc.||Apparatus and methods for deployment of multiple custom-length prostheses (ii)|
|US20090285975 *||Nov 19, 2009||Bates Brian L||Methods for making implantable medical devices|
|US20100042067 *||Aug 18, 2008||Feb 18, 2010||Cook Incorporated||Embolization particles and method for making same|
|US20100063585 *||Jul 3, 2007||Mar 11, 2010||Hemoteq Ag||Manufacture, method and use of active substance-releasing medical products for permanently keeping blood vessels open|
|US20100131044 *||Jul 13, 2007||May 27, 2010||Udayan Patel||Stent|
|US20100179475 *||Jan 21, 2008||Jul 15, 2010||Erika Hoffmann||Medical product for treating stenosis of body passages and for preventing threatening restenosis|
|US20100272773 *||Oct 28, 2010||Boston Scientific Scimed, Inc.||Use of Drug Polymorphs to Achieve Controlled Drug Delivery From a Coated Medical Device|
|US20100274347 *||Jul 15, 2010||Oct 28, 2010||Advanced Bio Prosthetic Surfaces, Ltd.,a wholly owned subsidiary of Palmaz Scientific, Inc.||Endoluminal device for in vivo delivery of bioactive agents|
|US20120259401 *||Oct 11, 2012||Gerrans Lawrence J||Balloon catheter for launching drug delivery device|
|DE4310378A1 *||Mar 30, 1993||Oct 6, 1994||Aigner Karl||Ballonkatheter und Vorrichtung zur isolierten Persfusion mittels des Ballonkatheters|
|DE4324218A1 *||Jul 19, 1993||Jan 26, 1995||Bavaria Med Tech||Manschettenkatheter|
|EP0681475A1 *||Jan 26, 1994||Nov 15, 1995||Neorx Corporation||Therapeutic inhibitors of vascular smooth muscle cells|
|EP0825887A1 *||Mar 29, 1995||Mar 4, 1998||Boston Scientific Corporation||Drug treatment of diseased sites deep within the body|
|EP1447098A2||Jan 26, 1994||Aug 18, 2004||Boston Scientific Limited||Therapeutic inhibitor of vascular smooth muscle cells|
|EP1484081A1 *||Sep 24, 1999||Dec 8, 2004||C.R. Bard Inc.||Systems and methods for treating ischemia|
|EP1773439A2 *||Jul 14, 2005||Apr 18, 2007||By-Pass, Inc.||Material delivery system|
|EP2305321A1||Nov 19, 2001||Apr 6, 2011||Advanced Bio Prosthetic Surfaces, Ltd.||Device for in vivo delivery of bioactive agents and method of manufacture thereof|
|WO1994016706A1||Jan 26, 1994||Aug 4, 1994||Neorx Corp||Therapeutic inhibitors of vascular smooth muscle cells|
|WO1994023669A1 *||Apr 11, 1994||Oct 27, 1994||Boston Scient Corp||Prosthesis delivery system with dilating tip|
|WO1995003081A1 *||Oct 13, 1993||Feb 2, 1995||Bavaria Med Tech||Sleeve cathether|
|WO1996008286A1 *||Aug 8, 1995||Mar 21, 1996||Localmed Inc||Catheter sleeve and method of use|
|WO1998057591A1 *||Jun 15, 1998||Dec 23, 1998||Scimed Life Systems Inc||Percutaneous chamber-to-artery bypass|
|WO1999030764A1 *||Dec 18, 1998||Jun 24, 1999||Bard Inc C R||Systems and methods for local delivery of an agent|
|WO2000016848A1 *||Sep 24, 1999||Mar 30, 2000||Bard Inc C R||Systems and methods for treating ischemia|
|WO2003072024A2 *||Feb 13, 2003||Sep 4, 2003||Beth Israel Hospital||Methods of treating vascular disease|
|WO2003072024A3 *||Feb 13, 2003||Feb 26, 2004||Fritz H Bach||Methods of treating vascular disease|
|WO2004064911A1 *||Jan 16, 2004||Aug 5, 2004||Samsung Life Public Welfare Fo||Stent for percutaneous coronary intervention, coated with vascular restenosis prevention drug|
|WO2012054129A1 *||Aug 16, 2011||Apr 26, 2012||Boston Scientific Scimed, Inc.||Drug eluting medical device utilizing bioadhesives|
|U.S. Classification||604/96.01, 604/913, 606/194|
|Jul 3, 1996||FPAY||Fee payment|
Year of fee payment: 4
|Aug 15, 2000||REMI||Maintenance fee reminder mailed|
|Jan 21, 2001||LAPS||Lapse for failure to pay maintenance fees|
|Mar 27, 2001||FP||Expired due to failure to pay maintenance fee|
Effective date: 20010119